{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:52:40Z","timestamp":1793141560550,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajt.2025.03.022","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:47:09Z","timestamp":1743464829000},"page":"1491-1501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting the success of antibody removal with therapeutic plasma exchange: The role of serum dilutions"],"prefix":"10.1016","volume":"25","author":[{"given":"Nidhi","family":"Vantair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Leising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-8783","authenticated-orcid":false,"given":"Matthew","family":"Najor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Juma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyang","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-1377","authenticated-orcid":false,"given":"Jennifer E.","family":"Verbesey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-9475","authenticated-orcid":false,"given":"Farooq H.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-515X","authenticated-orcid":false,"given":"Alaa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-3321","authenticated-orcid":false,"given":"Anne","family":"Renteria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3438-9638","authenticated-orcid":false,"given":"Matthew","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rosen-Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-6683","authenticated-orcid":false,"given":"Olga A.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajt.2025.03.022_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cll.2018.10.007","article-title":"Donor-specific HLA antibodies as biomarkers of transplant rejection","volume":"39","author":"Timofeeva","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.ajt.2025.03.022_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916200","article-title":"Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection","volume":"13","author":"Krummey","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.022_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2025.03.022_bib4","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.03.022_bib5","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/TP.0000000000002333","article-title":"Understanding the correlation between DSA, complement activation, and antibody-mediated rejection in heart transplant recipients","volume":"102","author":"Zhang","year":"2018","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.022_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1513\/AnnalsATS.201812-869OC","article-title":"Clinical outcomes of lung transplantation in the presence of donor-specific antibodies","volume":"16","author":"Courtwright","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.022_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/TP.0000000000004412","article-title":"Removing barriers and mitigating risk: the case for crossing donor-specific antibodies in lung transplantation with the use of perioperative desensitization","volume":"107","author":"Aversa","year":"2023","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.022_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15625","article-title":"A simple predictor for donor-specific anti-HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation","volume":"104","author":"Li","year":"2024","journal-title":"HLA"},{"issue":"11","key":"10.1016\/j.ajt.2025.03.022_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/TP.0b013e3181fa93c6","article-title":"Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies","volume":"90","author":"Bu\u0107in","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.htct.2024.02.001","article-title":"Therapeutic plasma exchange and HLA desensitization","volume":"46","author":"Rego","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.022_bib11","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/ajt.14912","article-title":"Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation","volume":"18","author":"Ius","year":"2018","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.022_bib12","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.transproceed.2005.09.128","article-title":"Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation","volume":"37","author":"Ibern\u00f3n","year":"2005","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.ajt.2025.03.022_bib13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0b013e3181a6bac5","article-title":"Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection","volume":"87","author":"Fehr","year":"2009","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/tri.13825","article-title":"Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients\u2014a retrospective study","volume":"34","author":"Timofeeva","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.ajt.2025.03.022_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2020.101274","article-title":"Serum dilutions as a predictive biomarker for peri-operative desensitization: an exploratory approach to transplanting sensitized heart candidates","volume":"60","author":"Timofeeva","year":"2020","journal-title":"Transpl Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.ajt.2025.03.022_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.022_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the Ninth Special Issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ajt.2025.03.022_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-493-7_2","article-title":"Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury","volume":"1034","author":"Valenzuela","year":"2013","journal-title":"Methods Mol Biol."},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/1744-9987.12465","article-title":"Removal dynamics of immunoglobulin and fibrinogen by conventional plasma exchange, selective plasma exchange, and a combination of the two","volume":"20","author":"Miyamoto","year":"2016","journal-title":"Ther Apher Dial"},{"issue":"7","key":"10.1016\/j.ajt.2025.03.022_bib20","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.3390\/ijms24076552","article-title":"Immunomodulatory aspects of therapeutic plasma exchange in neurological disorders-a pilot study","volume":"24","author":"Foettinger","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.022_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the Transplantion Society Working Group","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.022_bib22","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"issue":"1S Suppl 1","key":"10.1016\/j.ajt.2025.03.022_bib23","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0000000000001817","article-title":"HLA diagnostics: evaluating DSA strength by titration","volume":"102","author":"Tambur","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.022_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/tan.14781","article-title":"Clinical utility of serial serum dilutions for HLA antibody interpretation","volume":"100","author":"Tambur","year":"2022","journal-title":"HLA"},{"issue":"7","key":"10.1016\/j.ajt.2025.03.022_bib25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"issue":"7-8","key":"10.1016\/j.ajt.2025.03.022_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.humimm.2017.05.001","article-title":"It\u2019s about time: the development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen","volume":"78","author":"Liwski","year":"2017","journal-title":"Hum Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2025.03.022_bib27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.03.022_bib28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib29","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1016\/j.healun.2024.02.509","article-title":"Clinical utility of 1:16 serum dilution as a predictor of response to therapeutic plasma exchange for HLA antibody-mediated rejection treatment in lung transplant recipients: a two center study","volume":"43","author":"Elrefaei","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.022_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ajt.15007","article-title":"Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy","volume":"19","author":"Pinelli","year":"2019","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/trf.12923","article-title":"Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients","volume":"55","author":"Yamada","year":"2015","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.022_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001695","article-title":"Anti-HLA Class II antibodies are the most resistant to desensitization in crossmatch-positive living-donor kidney transplantations: a patient series","volume":"10","author":"de Weerd","year":"2024","journal-title":"Transplant Direct"},{"issue":"7","key":"10.1016\/j.ajt.2025.03.022_bib33","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral compensation after bortezomib treatment of allosensitized recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ajt.2025.03.022_bib34","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/TP.0000000000001330","article-title":"32 doses of bortezomib for desensitization is not well tolerated and is associated with only modest reductions in anti-HLA antibody","volume":"101","author":"Moreno Gonzales","year":"2017","journal-title":"Transplantation"},{"issue":"23","key":"10.1016\/j.ajt.2025.03.022_bib35","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1111\/jcmm.16998","article-title":"Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression","volume":"25","author":"Cheng","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.transproceed.2020.01.067","article-title":"Antibody-mediated rejection treatment with bortezomib in renal transplant recipients: a single-center 24-month follow-up case report","volume":"52","author":"Bahena M\u00e9ndez","year":"2020","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.022_bib37","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.1016\/j.healun.2019.01.1192","article-title":"Use of bortezomib in the treatment of antibody mediated rejection (AMR) in pediatric heart recipients","volume":"38","author":"Otero","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.03.022_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2025.03.022_bib39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3349\/ymj.2015.56.6.1638","article-title":"The effect of bortezomib on antibody-mediated rejection after kidney transplantation","volume":"56","author":"Lee","year":"2015","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.022_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12882-025-03951-5","article-title":"Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study","volume":"26","author":"Guo","year":"2025","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.022_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG Endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:23:02Z","timestamp":1751397782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1600613525001613"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.03.022","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the success of antibody removal with therapeutic plasma exchange: The role of serum dilutions","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}